Oliver wyman enters into agreement to acquire huron's life sciences strategy consulting practice

New york--(business wire)--oliver wyman, a global management consulting firm and a business of marsh mclennan [nyse: mmc] today announced that it has entered into an agreement to acquire huron's life sciences strategy consulting practice. huron is recognized in the market for its expert life sciences strategy business, helping clients address their most important commercial, marketing, pricing, market access, and r&d challenges. huron's senior professionals have longstanding relationships a
MMC Ratings Summary
MMC Quant Ranking